In 2023, neoplasms mortality in the US was recorded at 330.11 thousand male deaths. The forecast for the years 2024 to 2028 shows a consistent increase in male deaths due to neoplasms, from 331.32 thousand in 2024 to 336.11 thousand in 2028. This suggests a steady year-on-year increase, approximately 0.4% annually. Over the last two years, the increase rate is consistent, reinforcing the ongoing upward trend in males’ mortality related to neoplasms. The average annual growth rate over the five-year period from 2023 to 2028 is around 0.4%.
Future trends to watch for include advancements in treatment and prevention strategies, which could potentially reverse or slow down the increasing trend. Additionally, shifts in population demographics, healthcare access, and lifestyle changes could impact future mortality rates.
